rdf:type |
|
lifeskim:mentions |
umls-concept:C0018338,
umls-concept:C0086418,
umls-concept:C0205198,
umls-concept:C0205245,
umls-concept:C0205307,
umls-concept:C0205409,
umls-concept:C0871261,
umls-concept:C1514521,
umls-concept:C1533691,
umls-concept:C1704259,
umls-concept:C1704632,
umls-concept:C1705987,
umls-concept:C1706817,
umls-concept:C2911692
|
pubmed:issue |
6
|
pubmed:dateCreated |
2006-6-12
|
pubmed:abstractText |
To examine the effects of some nitric oxide-donating agents, as well as the C-type natriuretic peptide (CNP), on isolated human prostatic tissue. To date, guanylyl cyclases and cyclic guanosine monophosphate (cGMP)-degrading phosphodiesterases represent important target proteins for the development of new drugs for the treatment of lower urinary tract symptoms and benign prostatic hyperplasia.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1527-9995
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
67
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1292-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
|
pubmed:year |
2006
|
pubmed:articleTitle |
In vitro functional responses of isolated normal human prostatic tissue to compounds interacting with the cyclic guanosine monophosphate pathway.
|
pubmed:affiliation |
Department of Urology, Hannover Medical School, Hannover, Germany. sue_de_99@yahoo.de
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|